Use of prolonged travel to improve pediatric risk-adjustment models

Scott A Lorch1, Jeffrey H Silber, Orit Even-Shoshan

  • 1Center for Outcomes Research, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. lorch@email.chop.edu

Health Services Research
|February 12, 2009
PubMed

Insights

Travel distance and time significantly impact pediatric hospital outcomes. Accounting for travel variables in risk adjustment improves comparisons of hospital quality, especially for children's hospitals.

Area of Science:

  • Healthcare outcomes research
  • Pediatric health services research
  • Health informatics

Background:

  • Previous studies reported variations in length of stay (LOS), readmission rates, and mortality for pediatric patients treated at children's hospitals versus other hospital types.
  • These differences were not fully explained by traditional risk-adjustment models.

Purpose of the Study:

  • To investigate if travel variables can account for previously observed disparities in pediatric patient outcomes.
  • To assess the impact of travel distance and time on length of stay, readmission, and mortality.
  • To improve the accuracy of hospital quality assessments by incorporating travel factors.

Main Methods:

  • Analysis of Pennsylvania hospital discharge data (1996-1998).
  • Creation of a cohort of 51,855 children (aged 1-17) with common pediatric conditions.
  • Development of regression models to compare outcomes (LOS, readmission, death) between children's and other hospitals, including travel variables alongside traditional illness severity measures.

Main Results:

  • Without travel variables, longer travel distances to children's or rural hospitals correlated with longer adjusted LOS and higher readmission rates.
  • Incorporating geocoded travel time or nongeocoded travel distance significantly reduced adjusted LOS, readmission rates, and mortality rates for children's and rural hospitals compared to other facilities.

Conclusions:

  • Travel variables are crucial for accurate risk adjustment in pediatric healthcare.
  • Adding travel metrics to severity adjustment models can mitigate systematic differences between hospitals.
  • This approach enhances the evaluation of individual hospital performance in pediatric care.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...